Lupus Nephritis Treatment Strategies

J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172. Online ahead of print.ABSTRACTLupus nephritis (LN) is present in approximately 25% to 50% of patients at the time of systemic lupus erythematosus diagnosis and eventually develops in up to 60% of adults and 80% of children.1 Over the past 5 decades, major advances in immunosuppressive medications for patients with severe LN (classes III, IV, and V alone or in combination) have resulted in significant improvements in patient survival.2.PMID:38561191 | DOI:10.3899/jrheum.2024-0172
Source: Journal of Rheumatology - Category: Rheumatology Authors: Source Type: research